Suppr超能文献

金属与塑料支架用于胰腺积液引流的比较:系统评价和荟萃分析。

Metal Versus Plastic Stents for Pancreatic Fluid Collection Drainage: A Systematic Review and Meta-analysis.

机构信息

Department of Gastroenterology, Changhai Hospital.

Outpatient Department of Changhai Hospital, Naval Medical University, Shanghai, China.

出版信息

J Clin Gastroenterol. 2021 Sep 1;55(8):652-660. doi: 10.1097/MCG.0000000000001539.

Abstract

OBJECTIVES

The therapeutic efficacy of metal stents (MSs) for pancreatic fluid collections (PFCs) is invariably controversial. Here, we conducted a meta-analysis to summarize the results of efficacy of MSs and plastic stents (PSs) in PFC drainage.

SUBJECTS AND METHODS

We performed a literature search of PubMed/MEDLINE, EMBASE, and COCHRANE for all of the published studies regarding the use of MSs and PSs for endoscopic transmural drainage of PFCs from January, 1 2015 to June 1, 2020. We extracted data from 9 studies (1359 patients) that met the inclusion criteria. The main outcome measures were the rates of treatment success, including technique success and clinical success (CS), adverse events, recurrence, procedure time, and length of hospital stay (LOS).

RESULTS

There was no difference in overall technique success between patients treated with MSs and PSs for PFCs. However, MSs showed a higher CS rate 92% versus 82% (P<0.01) and a lower overall adverse event rate 20% versus 31% (P<0.01) than PSs. The recurrence rate of PFCs using MSs also had significant advantages over PSs 3% versus 10% (P<0.01) and MSs needed a shorter procedure time than PSs (26.73 vs. 45.40 min, P<0.01). In comparing direct endoscopic necrosectomy use and LOS, there was no difference between MSs and PSs.

CONCLUSIONS

Bringing together the results of the current study, endoscopic ultrasound-guided drainage of PFCs using MSs may be superior to PSs in terms of CS, adverse events rates and recurrence rate, with similar LOS and direct endoscopic necrosectomy use.

摘要

目的

金属支架(MS)治疗胰腺液体积聚(PFC)的疗效一直存在争议。在此,我们进行了一项荟萃分析,以总结 MS 和塑料支架(PS)在 PFC 引流中的疗效结果。

受试者和方法

我们对 2015 年 1 月至 2020 年 6 月期间发表的所有关于 MS 和 PS 用于内镜经壁引流 PFC 的研究进行了 PubMed/MEDLINE、EMBASE 和 Cochrane 文献检索。我们从符合纳入标准的 9 项研究(1359 例患者)中提取数据。主要观察指标为治疗成功率,包括技术成功率和临床成功率(CS)、不良事件、复发、操作时间和住院时间(LOS)。

结果

MS 和 PS 治疗 PFC 的总体技术成功率无差异。然而,MS 的 CS 率(92%比 82%,P<0.01)和总体不良事件率(20%比 31%,P<0.01)均高于 PS。MS 治疗 PFC 的复发率也明显优于 PS(3%比 10%,P<0.01),且操作时间短于 PS(26.73 比 45.40 分钟,P<0.01)。在比较直接内镜下坏死组织清除术的使用和 LOS 时,MS 和 PS 之间无差异。

结论

综合本研究结果,与 PS 相比,MS 经内镜超声引导引流 PFC 可能在 CS、不良事件发生率和复发率方面具有优势,而 LOS 和直接内镜下坏死组织清除术的使用无差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验